EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Comparison of long-term outcomes between endoscopic submucosal dissection and esophagectomy for superficial esophageal squamous cell carcinoma

Byeong Yun Ahn, Quanxin Zheng, Soo-Jeong Cho, Sang Gyun Kim, Chang Hyun Kang iD, Hyunsoo Chung iD

Gastroenterology Report · 20.01.2026 · 14

DOI: 10.1093/gastro/goag032 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Gastroenterology Report, online erschienen am 19.04.2026. Verfasst von Byeong Yun Ahn und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine & Liver Research Institute, Seoul National University College of Medicine, Seoul, South Korea. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Endoscopic submucosal dissection (ESD) is increasingly being performed as a less invasive alternative to esophagectomy for superficial esophageal squamous cell carcinoma (SESCC); however, comparative long-term outcome data, especially for non-curative resection (non-CR) cases and elderly patients, remain limited. This study aimed to compare the clinical outcomes of ESD and esophagectomy using a propensity score (PS)–matched cohort.

Methods

Patients with SESCC who underwent ESD or esophagectomy at a tertiary referral center between 2011 and 2021 were retrospectively reviewed. In the PS-matched cohort, overall survival (OS), disease-specific survival (DSS), recurrence-free survival (RFS), additional treatments, and adverse events were compared. Subgroup analyses were conducted for non-CR cases and elderly patients (≥70 years).

Results

Among the 63 PS-matched pairs, OS, DSS, and RFS were comparable between the ESD and esophagectomy groups. The 5-year OS, DSS, and RFS rates were 89.9% versus 79.2%, 95.7% versus 94.4%, and 90.6% versus 89.1%, respectively. The ESD group had significantly fewer adverse events (47.6% vs 68.3%, P < 0.05) and a shorter median hospital stay (1.0 vs 10.0 days, P < 0.001) than the esophagectomy group. Survival outcomes were also similar in the non-CR and elderly subgroups.

Conclusions

ESD is a safe and effective alternative to esophagectomy for SESCC, including in non-CR and elderly patients. Given the limitations of preprocedural depth assessment and the high risk of complications associated with esophagectomy, staging ESD for SESCC may represent a reasonable treatment option, particularly for elderly or high-risk patients.

Schlagwörter

Stichwörter der Autor:innen

endoscopyesophageal squamous cell carcinomaesophagectomygastrointestinalpropensity scoretreatment outcome

Autor:innen und Institutionen

  • Department of Internal Medicine & Liver Research Institute, Seoul National University College of Medicine, Seoul, South Korea.
  • Department of Thoracic and Cardiovascular Surgery, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, South Korea.
  • Department of Medical Device Development, Seoul National University College of Medicine, Seoul, South Korea.

ORCID-Profile: Chang Hyun Kang, Hyunsoo Chung

Zitieren

APA

Ahn, B. Y., Zheng, Q., Cho, S. J., Kim, S. G., Kang, C. H., & Chung, H. (2026). Comparison of long-term outcomes between endoscopic submucosal dissection and esophagectomy for superficial esophageal squamous cell carcinoma. Gastroenterology Report, 14. https://doi.org/10.1093/gastro/goag032

Vancouver

Ahn BY, Zheng Q, Cho SJ, Kim SG, Kang CH, Chung H. Comparison of long-term outcomes between endoscopic submucosal dissection and esophagectomy for superficial esophageal squamous cell carcinoma. Gastroenterology Report. 2026;14. doi:10.1093/gastro/goag032

BibTeX
@article{Ahn2026,
  author = {Ahn, Byeong Yun and Zheng, Quanxin and Cho, Soo-Jeong and Kim, Sang Gyun and Kang, Chang Hyun and Chung, Hyunsoo},
  title = {Comparison of long-term outcomes between endoscopic submucosal dissection and esophagectomy for superficial esophageal squamous cell carcinoma},
  journal = {Gastroenterology Report},
  year = {2026},
  volume = {14},
  doi = {10.1093/gastro/goag032}
}
Kostenlos starten →